日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Asparagine synthetase regulates lung-cancer metastasis by stabilizing the β-catenin complex and modulating mitochondrial response

天冬酰胺合成酶通过稳定β-catenin复合物和调节线粒体反应来调控肺癌转移。

Cai, Dong-Jing; Zhang, Zi-Yu; Bu, Yue; Li, Li; Deng, Yue-Zhen; Sun, Lun-Quan; Hu, Cheng-Ping; Li, Min

Tumor-related cytokine release syndrome in a treatment-naïve patient with lung adenocarcinoma: A case report

一例未经治疗的肺腺癌患者发生肿瘤相关细胞因子释放综合征的病例报告

Deng, Peng-Bo; Jiang, Juan; Hu, Cheng-Ping; Cao, Li-Ming; Li, Min

Demographic Factors and Cognitive Function Assessments Associated with Mild Cognitive Impairment Progression for the Elderly

老年人轻度认知障碍进展相关的社会人口学因素和认知功能评估

Qin, Hong-Yun; Zhao, Xu-Dong; Zhu, Bing-Gen; Hu, Cheng-Ping

Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study

残余脂蛋白在接受经皮冠状动脉介入治疗的2型糖尿病患者的支架内再狭窄中起重要作用:一项单中心观察性队列研究

Qin, Zheng; Zhou, Kuo; Li, Yue-Ping; Wang, Jian-Long; Cheng, Wan-Jun; Hu, Cheng-Ping; Shi, Chao; He, Hua; Zhou, Yu-Jie

The in cis compound EGFR mutations in Chinese advanced non-small cell lung cancer patients

中国晚期非小细胞肺癌患者中顺式复合EGFR突变

Li, Min; Zhou, Cheng-Zhi; Yang, Jin-Ji; Lu, Shun; Zheng, Di; Hu, Jie; Zeng, Hui; Lu, You; Lu, Kai-Hua; Li, Shu-Ang; Mao, Xin-Ru; Han-Zhang, Han; Lizaso, Analyn; Ye, Jun-Yi; Hu, Cheng-Ping

Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention

入院时血小板分布宽度可预测接受经皮冠状动脉介入治疗的冠状动脉疾病合并2型糖尿病患者的支架内再狭窄

Hu, Cheng-Ping; Du, Yu; Zhu, Yong; Shi, Chao; Qin, Zheng; Zhao, Ying-Xin

Effects of Glucocorticoid-Induced Transcript 1 Gene Deficiency on Glucocorticoid Activation in Asthmatic Mice

糖皮质激素诱导转录物1基因缺陷对哮喘小鼠糖皮质激素激活的影响

Hu, Cheng-Ping; Xun, Qiu-Fen; Li, Xiao-Zhao; Hu, Xin-Yue; Qin, Ling; He, Ruo-Xi; Feng, Jun-Tao

Mutational landscape and clonal diversity of pulmonary adenoid cystic carcinoma

肺腺样囊性癌的突变图谱和克隆多样性

Li, Min; Zhao, Bing-Rong; Liu, Shi-Qing; An, Jian; Deng, Peng-Bo; Han-Zhang, Han; Ye, Jun-Yi; Mao, Xin-Ru; Chuai, Shao-Kun; Hu, Cheng-Ping

A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel

2017年中国肺癌峰会专家组关于免疫疗法的共识

Wu, Yi-Long; Wang, Chang-Li; Liao, Mei-Lin; Guan, Zhong-Zhen; Gao, Chen-Yan; Lu, Shun; Zhao, Ming-Fang; Wang, Jie; Liu, Xiao-Qing; Yang, Jin-Ji; Liang, Jun; Mao, Wei-Min; Han, Bao-Hui; Zhang, Xu-Chao; Song, Yong; Feng, Ji-Feng; Ma, Sheng-Lin; Wu, Gang; Zhou, Cai-Cun; Chen, Ke-Neng; Cheng, Ying; He, Yong; Chen, Chun; Wang, Qun; Lin, Ji-Zhen; Zhu, Bo; Liu, Yun-Peng; Hu, Yi; Qiao, Gui-Bin; Zhou, Qing; Song, Qi-Bin; Wu, Nan; Wu, Lin; Huang, Cheng; Fu, Xiao-Long; Xiong, Jian-Ping; Hu, Jie; Hu, Cheng-Ping; Chang, Jian-Hua; Zhao, Qiong; Zhao, Jun; Zhou, Peng-Hui; Ma, Zhi-Yong; Chen, Yuan; Zhang, He-Long; Yang, Fan; Wang, Jian-Jun; Pan, Yue-Yin; Yang, Xue-Ning; Fan, Yun; Liu, Zhe; Fan, Wen; Yang, Nong; Guan, Yan-Fang; Sun, Hao; Zhong, Wen-Zhao

Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung

阿法替尼与厄洛替尼用于中国晚期肺鳞状细胞癌患者二线治疗的比较

Lu, Shun; Li, Wei; Zhou, Caicun; Hu, Cheng-Ping; Qin, Shukui; Cheng, Gang; Feng, Jifeng; Wang, Jie; Cseh, Agnieszka; Peil, Barbara; Gibson, Neil; Ehrnrooth, Eva; Zhang, Li